Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00115934 · ClinicalTrials.gov registry record · NA

Comparison of Two Types of Shunts in Infants With Single Ventricle Defect Undergoing Staged Reconstruction--Pediatric Heart Network

A NA study, sponsored by Carelon Research.

Completed
Registry status
NA
Development phase
555
Enrollment target

NCT00115934 is a NA study that has completed, run by Carelon Research. The registered enrollment target is 555 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00115934, a NA study, has completed, sponsored by Carelon Research.

COMPLETED
Registry status
NA
Development phase
555 participants
Enrollment target

Study Summary

This trial will evaluate the efficacy and safety of the modified Blalock-Taussig shunt (MBTS) compared to the right ventricle to pulmonary artery (RV-to-PA) shunt; compare the effect of the MBTS to that of the RV-to-PA shunt on the incidence of death or cardiac transplantation at 12 months post randomization; and compare the effect of the two shunts on intensive care unit (ICU) morbidity, unintended cardiovascular interventional procedures, right ventricular function, tricuspid valve regurgitation, pulmonary artery growth, and neurodevelopmental outcome.

Interventions

  • PROCEDURE Blalock-Taussig pulmonary artery shunt
  • PROCEDURE Right ventricular to pulmonary artery shunt

Trial Details

FieldValue
Enrollment Target 555 participants
Start Date 2005-05
Est. Completion 2009-10
Phase NA

Sponsor

Carelon Research

50 total trials

What the Registry Record Tells You About NCT00115934

The ClinicalTrials.gov registry entry for NCT00115934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 555 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Blalock-Taussig pulmonary artery shunt is the first listed.

NCT00115934 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00115934 about?

NCT00115934 is a clinical study titled "Comparison of Two Types of Shunts in Infants With Single Ventricle Defect Undergoing Staged Reconstruction--Pediatric Heart Network". This trial will evaluate the efficacy and safety of the modified Blalock-Taussig shunt (MBTS) compared to the right ventricle to pulmonary artery (RV-to-PA) shunt; compare the effect of the MBTS to that of the RV-to-PA shunt on the incidence of death or cardiac transplantation at 12 months post rand...

What is the current status of trial NCT00115934?

This trial is currently completed. It is a NA study. The enrollment target is 555 participants. The study started on 2005-05. Estimated completion is 2009-10.

What interventions are being tested in trial NCT00115934?

The interventions under investigation include: Blalock-Taussig pulmonary artery shunt (PROCEDURE), Right ventricular to pulmonary artery shunt (PROCEDURE).

Who is sponsoring clinical trial NCT00115934?

This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.